Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3373 |  ACIU AC Immune SA - Common Stock | 2.55 USD | -0.78% | -10.21% | -6.59% | -27.14% | 259.44 M USD | ||
| 3383 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -0.93% | -8.97% | -11.98% | +32.30% | 255.22 M USD | ||
| 3387 |  STRO Sutro Biopharma, Inc. - Common Stock | 15.32 USD | +4.50% | -5.14% | -14.94% | -11.90% | 254.02 M USD | ||
| 3391 |  PALI Palisade Bio, Inc. - Common Stock | 1.45 USD | -2.03% | -0.68% | -29.27% | -14.71% | 252.69 M USD | ||
| 3420 |  IMRX Immuneering Corporation - Class A Common Stock | 3.74 USD | -3.11% | -8.78% | -17.44% | -40.35% | 241.97 M USD | ||
| 3450 |  EVMN Evommune, Inc. Common Stock | 6.40 USD | +2.89% | -10.86% | -39.05% | -63.05% | 232.27 M USD | ||
| 3454 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.82 USD | -7.14% | +8.98% | +62.50% | +100.00% | 231.60 M USD | ||
| 3459 |  KROS Keros Therapeutics, Inc. - common stock | 11.64 USD | +3.84% | +2.28% | +4.30% | -22.91% | 230.79 M USD | ||
| 3470 |  MGNX MacroGenics, Inc. - Common Stock | 3.55 USD | 0.00% | -2.47% | -12.99% | +100.56% | 226.14 M USD | ||
| 3471 |  ALEC Alector, Inc. - Common Stock | 2.02 USD | +5.21% | +5.76% | -9.01% | -36.08% | 225.55 M USD | ||
| 3481 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.14 USD | -1.62% | -14.22% | +4.13% | +33.86% | 222.23 M USD | ||
| 3484 |  SION Sionna Therapeutics, Inc. - Common Stock | 4.90 USD | +1.66% | -5.59% | -33.78% | -87.54% | 221.54 M USD | ||
| 3492 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.70 USD | -0.37% | -0.37% | +2.27% | -7.53% | 217.54 M USD | ||
| 3499 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 8.79 USD | +2.69% | -7.96% | -30.79% | -63.66% | 215.40 M USD | ||
| 3500 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 5.53 USD | -1.43% | +0.73% | -21.00% | -20.66% | 215.32 M USD | ||
| 3513 |  NAGE Niagen Bioscience, Inc. - Common Stock | 2.66 USD | -2.21% | -2.21% | -12.21% | -46.59% | 210.48 M USD | ||
| 3530 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.82 USD | +2.10% | -6.83% | -20.05% | -25.55% | 206.34 M USD | ||
| 3531 |  IVVD Invivyd, Inc. - Common Stock | 0.70 USD | -4.11% | -15.66% | -10.26% | -65.00% | 206.33 M USD | ||
| 3540 |  ADCT ADC Therapeutics SA Common Shares | 1.59 USD | +11.97% | +44.55% | +29.27% | -65.05% | 202.99 M USD | ||
| 3547 |  CGEN Compugen Ltd. - Ordinary Shares | 2.12 USD | -1.40% | -9.40% | -14.52% | +8.72% | 200.45 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |